Skip to content
OpenCapital
Get started

Thermo Fisher Scientific TMO Remaining performance obligations related to customer contracts that are unsatisfied or partially unsatisfied

Remaining performance obligations related to customer contracts that are unsatisfied or partially unsatisfied at other companies

Danaher logo
DanaherDHR
——
WAT
Waters CorporationWAT
——
Agilent Technologies logo
Agilent TechnologiesA
——
Bruker logo
BrukerBRKR
——
Illumina logo
IlluminaILMN
——
IQVIA logo
IQVIAIQV
——

Other financials

Income statement

See full
Revenue$11.0B+6.2%
Operating income$1.9B+8.6%
Net income$1.7B+9.6%
EPS (diluted)$4.43+11.3%

Balance sheet

See full
Cash & equivalents$3.3B-21.4%
Total debt$43.2B+16.6%
Total equity$51.9B+5.2%
Total assets$113.28B+14.4%

Cash flow

See full
Operating cash flow$1.2B+64.9%
CapEx$376.0M+3.9%
Free cash flow$816.0M+126%

Valuation

See full
Market cap$186.32B+25.0%
Enterprise value$226.2B+24.4%
P/E27.2×+4.6×
P/S4.3×-0.8×

Profitability

See full
Gross margin58.3%—
Operating margin17.2%+0.8pp
Net margin15.2%+1.0pp
FCF margin15.7%-2.1pp

Returns & leverage

See full
Return on equity13.5%-0.2pp
Debt / equity0.8×+0.1×
Current ratio1.5×-0.2×

Where this comes from

Reported directly by Thermo Fisher Scientific in its filing.

Tagged under the XBRL concept us-gaap:RevenueRemainingPerformanceObligation.

The official record: Thermo Fisher Scientific’s 10-Q, filed May 1, 2026, on SEC EDGAR. View the filing →

Ask your AI about Thermo Fisher Scientific's remaining performance obligations related to customer contracts that are unsatisfied or partially unsatisfied.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Thermo Fisher Scientific's remaining performance obligations related to customer contracts that are unsatisfied or partially unsatisfied?
Thermo Fisher Scientific (TMO) reported remaining performance obligations related to customer contracts that are unsatisfied or partially unsatisfied of $29.41B in Q1 2026.
How has Thermo Fisher Scientific's remaining performance obligations related to customer contracts that are unsatisfied or partially unsatisfied changed year-over-year?
Thermo Fisher Scientific's remaining performance obligations related to customer contracts that are unsatisfied or partially unsatisfied increased by 19.8% year-over-year, from $24.54B to $29.41B.
What is the long-term trend for Thermo Fisher Scientific's remaining performance obligations related to customer contracts that are unsatisfied or partially unsatisfied?
Over 3 years (2020 to 2023), Thermo Fisher Scientific's remaining performance obligations related to customer contracts that are unsatisfied or partially unsatisfied has grown at a 28.1% compound annual growth rate (CAGR), from $12.81B to $26.92B.